{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T23:26:37Z","timestamp":1778369197627,"version":"3.51.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior","doi-asserted-by":"publisher","award":["PN: 10103\/13-9"],"award-info":[{"award-number":["PN: 10103\/13-9"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00394-019-01895-9","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T11:20:53Z","timestamp":1547119253000},"page":"151-165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Chronic consumption of the dietary polyphenol chrysin attenuates metabolic disease in fructose-fed rats"],"prefix":"10.1007","volume":"59","author":[{"given":"Nelson","family":"Andrade","sequence":"first","affiliation":[]},{"given":"Sara","family":"Andrade","sequence":"additional","affiliation":[]},{"given":"Cla\u00fadia","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Ilda","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa","family":"Guard\u00e3o","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o T.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[]},{"given":"Elisa","family":"Keating","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0525-3416","authenticated-orcid":false,"given":"F\u00e1tima","family":"Martel","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"issue":"5","key":"1895_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome\u2014a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23(5):469\u2013480. \nhttps:\/\/doi.org\/10.1111\/j.1464-5491.2006.01858.x","journal-title":"Diabet Med"},{"key":"1895_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12986-016-0123-9","volume":"13","author":"SK Wong","year":"2016","unstructured":"Wong SK, Chin KY, Suhaimi FH, Fairus A, Ima-Nirwana S (2016) Animal models of metabolic syndrome: a review. Nutr Metab (Lond) 13:65. \nhttps:\/\/doi.org\/10.1186\/s12986-016-0123-9","journal-title":"Nutr Metab (Lond)"},{"issue":"1","key":"1895_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13073-016-0303-2","volume":"8","author":"CL Boulange","year":"2016","unstructured":"Boulange CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME (2016) Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med 8(1):42. \nhttps:\/\/doi.org\/10.1186\/s13073-016-0303-2","journal-title":"Genome Med"},{"issue":"12","key":"1895_CR4","doi-asserted-by":"publisher","first-page":"e80176","DOI":"10.1371\/journal.pone.0080176","volume":"8","author":"T Yamanaka","year":"2013","unstructured":"Yamanaka T, Fukuda T, Shirota S, Sawai Y, Murai T, Fujita N, Hosoi H (2013) The prevalence and characteristics of metabolic syndrome in patients with vertigo. PLoS One 8(12):e80176. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0080176","journal-title":"PLoS One"},{"issue":"9","key":"1895_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/nu8090577","volume":"8","author":"CR Toop","year":"2016","unstructured":"Toop CR, Gentili S (2016) Fructose beverage consumption induces a metabolic syndrome phenotype in the rat: a systematic review and meta-analysis. Nutrients 8(9):577. \nhttps:\/\/doi.org\/10.3390\/nu8090577","journal-title":"Nutrients"},{"issue":"5","key":"1895_CR6","doi-asserted-by":"publisher","first-page":"E685","DOI":"10.1152\/ajpendo.00283.2010","volume":"299","author":"MJ Dekker","year":"2010","unstructured":"Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K (2010) Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 299(5):E685\u2013E694. \nhttps:\/\/doi.org\/10.1152\/ajpendo.00283.2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"1895_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1152\/physrev.00019.2009","volume":"90","author":"L Tappy","year":"2010","unstructured":"Tappy L, Le KA (2010) Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 90(1):23\u201346. \nhttps:\/\/doi.org\/10.1152\/physrev.00019.2009","journal-title":"Physiol Rev"},{"key":"1895_CR8","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1017\/jns.2016.41","volume":"5","author":"AN Panche","year":"2016","unstructured":"Panche AN, Diwan AD, Chandra SR (2016) Flavonoids: an overview. J Nutr Sci 5:e47. \nhttps:\/\/doi.org\/10.1017\/jns.2016.41","journal-title":"J Nutr Sci"},{"issue":"1","key":"1895_CR9","doi-asserted-by":"publisher","first-page":"E67","DOI":"10.3390\/molecules23010067","volume":"23","author":"JJ Ramirez-Espinosa","year":"2017","unstructured":"Ramirez-Espinosa JJ, Saldana-Rios J, Garcia-Jimenez S, Villalobos-Molina R, Avila-Villarreal G, Rodriguez-Ocampo AN, Bernal-Fernandez G, Estrada-Soto S (2017) Chrysin induces antidiabetic, antidyslipidemic and anti-inflammatory effects in athymic nude diabetic mice. Molecules 23(1):E67. \nhttps:\/\/doi.org\/10.3390\/molecules23010067","journal-title":"Molecules"},{"key":"1895_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.phytochem.2017.09.016","volume":"145","author":"R Mani","year":"2018","unstructured":"Mani R, Natesan V (2018) Chrysin: sources, beneficial pharmacological activities, and molecular mechanism of action. Phytochemistry 145:187\u2013196. \nhttps:\/\/doi.org\/10.1016\/j.phytochem.2017.09.016","journal-title":"Phytochemistry"},{"key":"1895_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jff.2017.07.032","volume":"36","author":"N Andrade","year":"2017","unstructured":"Andrade N, Ara\u00fajo JR, Correia-Branco A, Carletti JV, Martel F (2017) Effect of dietary polyphenols on fructose uptake by human intestinal epithelial (Caco-2) cells. J Funct Foods 36:429\u2013439. \nhttps:\/\/doi.org\/10.1016\/j.jff.2017.07.032","journal-title":"J Funct Foods"},{"issue":"3","key":"1895_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/ar.22641","volume":"296","author":"EC Jensen","year":"2013","unstructured":"Jensen EC (2013) Quantitative analysis of histological staining and fluorescence using ImageJ. Anat Rec (Hoboken) 296(3):378\u2013381. \nhttps:\/\/doi.org\/10.1002\/ar.22641","journal-title":"Anat Rec (Hoboken)"},{"key":"1895_CR13","doi-asserted-by":"publisher","first-page":"384583","DOI":"10.1155\/2014\/384583","volume":"2014","author":"CD Pereira","year":"2014","unstructured":"Pereira CD, Severo M, Araujo JR, Guimaraes JT, Pestana D, Santos A, Ferreira R, Ascensao A, Magalhaes J, Azevedo I, Monteiro R, Martins MJ (2014) Relevance of a hypersaline sodium-rich naturally sparkling mineral water to the protection against metabolic syndrome induction in fructose-fed Sprague\u2013Dawley rats: a biochemical, metabolic, and redox approach. Int J Endocrinol 2014:384583. \nhttps:\/\/doi.org\/10.1155\/2014\/384583","journal-title":"Int J Endocrinol"},{"issue":"9","key":"1895_CR14","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.nut.2016.02.007","volume":"32","author":"JH Choi","year":"2016","unstructured":"Choi JH, Yun JW (2016) Chrysin induces brown fat-like phenotype and enhances lipid metabolism in 3T3-L1 adipocytes. Nutrition 32(9):1002\u20131010. \nhttps:\/\/doi.org\/10.1016\/j.nut.2016.02.007","journal-title":"Nutrition"},{"issue":"11","key":"1895_CR15","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1002\/ptr.4917","volume":"27","author":"HM El-Bassossy","year":"2013","unstructured":"El-Bassossy HM, Abo-Warda SM, Fahmy A (2013) Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: effect on lipid profile, AGEs and NO generation. Phytother Res 27(11):1678\u20131684. \nhttps:\/\/doi.org\/10.1002\/ptr.4917","journal-title":"Phytother Res"},{"issue":"10","key":"1895_CR16","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s10072-014-1784-7","volume":"35","author":"R Li","year":"2014","unstructured":"Li R, Zang A, Zhang L, Zhang H, Zhao L, Qi Z, Wang H (2014) Chrysin ameliorates diabetes-associated cognitive deficits in Wistar rats. Neurol Sci 35(10):1527\u20131532. \nhttps:\/\/doi.org\/10.1007\/s10072-014-1784-7","journal-title":"Neurol Sci"},{"key":"1895_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cbi.2016.03.015","volume":"250","author":"N Rani","year":"2016","unstructured":"Rani N, Bharti S, Bhatia J, Nag TC, Ray R, Arya DS (2016) Chrysin, a PPAR-gamma agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation. Chem Biol Interact 250:59\u201367. \nhttps:\/\/doi.org\/10.1016\/j.cbi.2016.03.015","journal-title":"Chem Biol Interact"},{"issue":"4","key":"1895_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1139\/cjpp-2014-0412","volume":"94","author":"S Samarghandian","year":"2016","unstructured":"Samarghandian S, Azimi-Nezhad M, Samini F, Farkhondeh T (2016) Chrysin treatment improves diabetes and its complications in liver, brain, and pancreas in streptozotocin-induced diabetic rats. Can J Physiol Pharmacol 94(4):388\u2013393. \nhttps:\/\/doi.org\/10.1139\/cjpp-2014-0412","journal-title":"Can J Physiol Pharmacol"},{"key":"1895_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.etap.2017.01.013","volume":"50","author":"J Singh","year":"2017","unstructured":"Singh J, Chaudhari BP, Kakkar P (2017) Baicalin and chrysin mixture imparts cyto-protection against methylglyoxal induced cytotoxicity and diabetic tubular injury by modulating RAGE, oxidative stress and inflammation. Environ Toxicol Pharmacol 50:67\u201375. \nhttps:\/\/doi.org\/10.1016\/j.etap.2017.01.013","journal-title":"Environ Toxicol Pharmacol"},{"issue":"8","key":"1895_CR20","doi-asserted-by":"publisher","first-page":"E1046","DOI":"10.3390\/nu10081046","volume":"10","author":"MK Kang","year":"2018","unstructured":"Kang MK, Lee EJ, Kim YH, Kim DY, Oh H, Kim SI, Kang YH (2018) Chrysin ameliorates malfunction of retinoid visual cycle through blocking activation of AGE-RAGE-ER stress in glucose-stimulated retinal pigment epithelial cells and diabetic eyes. Nutrients 10(8):E1046. \nhttps:\/\/doi.org\/10.3390\/nu10081046","journal-title":"Nutrients"},{"issue":"7","key":"1895_CR21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00109-015-1301-3","volume":"93","author":"MK Kang","year":"2015","unstructured":"Kang MK, Park SH, Choi YJ, Shin D, Kang YH (2015) Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition. J Mol Med (Berl) 93(7):759\u2013772. \nhttps:\/\/doi.org\/10.1007\/s00109-015-1301-3","journal-title":"J Mol Med (Berl)"},{"issue":"12","key":"1895_CR22","doi-asserted-by":"publisher","first-page":"E782","DOI":"10.3390\/nu8120782","volume":"8","author":"MK Kang","year":"2016","unstructured":"Kang MK, Park SH, Kim YH, Lee EJ, Antika LD, Kim DY, Choi YJ, Kang YH (2016) Dietary compound chrysin inhibits retinal neovascularization with abnormal capillaries in db\/db mice. Nutrients 8(12):E782. \nhttps:\/\/doi.org\/10.3390\/nu8120782","journal-title":"Nutrients"},{"issue":"8","key":"1895_CR23","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/aps.2017.30","volume":"38","author":"MK Kang","year":"2017","unstructured":"Kang MK, Park SH, Kim YH, Lee EJ, Antika LD, Kim DY, Choi YJ, Kang YH (2017) Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2alpha-ATF-CHOP pathway in diabetic mice. Acta Pharmacol Sin 38(8):1129\u20131140. \nhttps:\/\/doi.org\/10.1038\/aps.2017.30","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"1895_CR24","doi-asserted-by":"publisher","first-page":"E882","DOI":"10.3390\/nu10070882","volume":"10","author":"EJ Lee","year":"2018","unstructured":"Lee EJ, Kang MK, Kim DY, Kim YH, Oh H, Kang YH (2018) Chrysin inhibits advanced glycation end products-induced kidney fibrosis in renal mesangial cells and diabetic kidneys. Nutrients 10(7):E882. \nhttps:\/\/doi.org\/10.3390\/nu10070882","journal-title":"Nutrients"},{"issue":"1","key":"1895_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2014.05.007","volume":"279","author":"A Ahad","year":"2014","unstructured":"Ahad A, Ganai AA, Mujeeb M, Siddiqui WA (2014) Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats. Toxicol Appl Pharmacol 279(1):1\u20137. \nhttps:\/\/doi.org\/10.1016\/j.taap.2014.05.007","journal-title":"Toxicol Appl Pharmacol"},{"issue":"10","key":"1895_CR26","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1177\/0960327112472993","volume":"32","author":"D Sirovina","year":"2013","unstructured":"Sirovina D, Orsolic N, Koncic MZ, Kovacevic G, Benkovic V, Gregorovic G (2013) Quercetin vs chrysin: effect on liver histopathology in diabetic mice. Hum Exp Toxicol 32(10):1058\u20131066. \nhttps:\/\/doi.org\/10.1177\/0960327112472993","journal-title":"Hum Exp Toxicol"},{"issue":"5","key":"1895_CR27","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1142\/S0192415X14500724","volume":"42","author":"HM El-Bassossy","year":"2014","unstructured":"El-Bassossy HM, Abo-Warda SM, Fahmy A (2014) Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-gamma activation. Am J Chin Med 42(5):1153\u20131167. \nhttps:\/\/doi.org\/10.1142\/S0192415X14500724","journal-title":"Am J Chin Med"},{"issue":"7","key":"1895_CR28","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jnutbio.2015.02.004","volume":"26","author":"MC Litterio","year":"2015","unstructured":"Litterio MC, Vazquez Prieto MA, Adamo AM, Elesgaray R, Oteiza PI, Galleano M, Fraga CG (2015) (\u2212)-Epicatechin reduces blood pressure increase in high-fructose-fed rats: effects on the determinants of nitric oxide bioavailability. J Nutr Biochem 26(7):745\u2013751. \nhttps:\/\/doi.org\/10.1016\/j.jnutbio.2015.02.004","journal-title":"J Nutr Biochem"},{"issue":"6","key":"1895_CR29","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.nut.2015.01.003","volume":"31","author":"A Novak","year":"2015","unstructured":"Novak A, Godoy YC, Martinez SA, Ghanem CI, Celuch SM (2015) Fructose-induced metabolic syndrome decreases protein expression and activity of intestinal P-glycoprotein. Nutrition 31(6):871\u2013876. \nhttps:\/\/doi.org\/10.1016\/j.nut.2015.01.003","journal-title":"Nutrition"},{"key":"1895_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejphar.2015.11.043","volume":"770","author":"CX Ge","year":"2016","unstructured":"Ge CX, Yu R, Xu MX, Li PQ, Fan CY, Li JM, Kong LD (2016) Betaine prevented fructose-induced NAFLD by regulating LXRalpha\/PPARalpha pathway and alleviating ER stress in rats. Eur J Pharmacol 770:154\u2013164. \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2015.11.043","journal-title":"Eur J Pharmacol"},{"issue":"1 Pt 1","key":"1895_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/s0895-7061(01)02232-4","volume":"15","author":"K Kamide","year":"2002","unstructured":"Kamide K, Rakugi H, Higaki J, Okamura A, Nagai M, Moriguchi K, Ohishi M, Satoh N, Tuck ML, Ogihara T (2002) The renin\u2013angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats. Am J Hypert 15(1 Pt 1):66\u201371. \nhttps:\/\/doi.org\/10.1016\/s0895-7061(01)02232-4","journal-title":"Am J Hypert"},{"issue":"11","key":"1895_CR32","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.3945\/jn.109.105858","volume":"139","author":"T Kawasaki","year":"2009","unstructured":"Kawasaki T, Igarashi K, Koeda T, Sugimoto K, Nakagawa K, Hayashi S, Yamaji R, Inui H, Fukusato T, Yamanouchi T (2009) Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J Nutr 139(11):2067\u20132071. \nhttps:\/\/doi.org\/10.3945\/jn.109.105858","journal-title":"J Nutr"},{"issue":"6","key":"1895_CR33","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/hep.23535","volume":"51","author":"MF Abdelmalek","year":"2010","unstructured":"Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, Diehl AM, Nonalcoholic Steatohepatitis Clinical Research N (2010) Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51(6):1961\u20131971. \nhttps:\/\/doi.org\/10.1002\/hep.23535","journal-title":"Hepatology"},{"issue":"1","key":"1895_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.taap.2010.11.011","volume":"251","author":"L Vila","year":"2011","unstructured":"Vila L, Rebollo A, Adalsteisson GS, Alegret M, Merlos M, Roglans N, Laguna JC (2011) Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment. Toxicol Appl Pharmacol 251(1):32\u201340. \nhttps:\/\/doi.org\/10.1016\/j.taap.2010.11.011","journal-title":"Toxicol Appl Pharmacol"},{"issue":"11","key":"1895_CR35","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0895-7061(03)01002-1","volume":"16","author":"C Catena","year":"2003","unstructured":"Catena C, Giacchetti G, Novello M, Colussi G, Cavarape A, Sechi LA (2003) Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension*. Am J Hypertens 16(11):973\u2013978. \nhttps:\/\/doi.org\/10.1016\/S0895-7061(03)01002-1","journal-title":"Am J Hypertens"},{"issue":"4","key":"1895_CR36","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/01.mco.0000232910.61612.4d","volume":"9","author":"KA Le","year":"2006","unstructured":"Le KA, Tappy L (2006) Metabolic effects of fructose. Curr Opin Clin Nutr Metab Care 9(4):469\u2013475. \nhttps:\/\/doi.org\/10.1097\/01.mco.0000232910.61612.4d","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"1895_CR37","doi-asserted-by":"publisher","first-page":"R1370","DOI":"10.1152\/ajpregu.00195.2008","volume":"295","author":"A Shapiro","year":"2008","unstructured":"Shapiro A, Mu W, Roncal C, Cheng KY, Johnson RJ, Scarpace PJ (2008) Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol 295(5):R1370\u2013R1375. \nhttps:\/\/doi.org\/10.1152\/ajpregu.00195.2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"1895_CR38","doi-asserted-by":"publisher","first-page":"e11376","DOI":"10.1371\/journal.pone.0011376","volume":"5","author":"ZA Knight","year":"2010","unstructured":"Knight ZA, Hannan KS, Greenberg ML, Friedman JM (2010) Hyperleptinemia is required for the development of leptin resistance. PLoS One 5(6):e11376. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0011376","journal-title":"PLoS One"},{"issue":"3","key":"1895_CR39","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/hep.21499","volume":"45","author":"N Roglans","year":"2007","unstructured":"Roglans N, Vila L, Farre M, Alegret M, Sanchez RM, Vazquez-Carrera M, Laguna JC (2007) Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats. Hepatology 45(3):778\u2013788. \nhttps:\/\/doi.org\/10.1002\/hep.21499","journal-title":"Hepatology"},{"issue":"6","key":"1895_CR40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nm1775","volume":"14","author":"C Buettner","year":"2008","unstructured":"Buettner C, Muse ED, Cheng A, Chen L, Scherer T, Pocai A, Su K, Cheng B, Li X, Harvey-White J, Schwartz GJ, Kunos G, Rossetti L, Buettner C (2008) Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nat Med 14(6):667\u2013675. \nhttps:\/\/doi.org\/10.1038\/nm1775","journal-title":"Nat Med"},{"key":"1895_CR41","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/sj.ijo.0802753","volume":"28","author":"RH Lustig","year":"2004","unstructured":"Lustig RH, Sen S, Soberman JE, Velasquez-Mieyer PA (2004) Obesity, leptin resistance, and the effects of insulin reduction. Int J Obes 28:1344. \nhttps:\/\/doi.org\/10.1038\/sj.ijo.0802753","journal-title":"Int J Obes"},{"issue":"5","key":"1895_CR42","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1161\/01.HYP.0000164570.20420.67","volume":"45","author":"Z Ackerman","year":"2005","unstructured":"Ackerman Z, Oron-Herman M, Grozovski M, Rosenthal T, Pappo O, Link G, Sela BA (2005) Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension 45(5):1012\u20131018. \nhttps:\/\/doi.org\/10.1161\/01.HYP.0000164570.20420.67","journal-title":"Hypertension"},{"issue":"6","key":"1895_CR43","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jnutbio.2012.09.002","volume":"24","author":"BN Bursac","year":"2013","unstructured":"Bursac BN, Djordjevic AD, Vasiljevic AD, Milutinovic DD, Velickovic NA, Nestorovic NM, Matic GM (2013) Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue. J Nutr Biochem 24(6):1166\u20131172. \nhttps:\/\/doi.org\/10.1016\/j.jnutbio.2012.09.002","journal-title":"J Nutr Biochem"},{"issue":"5","key":"1895_CR44","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.bbadis.2008.02.007","volume":"1782","author":"HY Koo","year":"2008","unstructured":"Koo HY, Wallig MA, Chung BH, Nara TY, Cho BH, Nakamura MT (2008) Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver. Biochim Biophys Acta 1782(5):341\u2013348. \nhttps:\/\/doi.org\/10.1016\/j.bbadis.2008.02.007","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1895_CR45","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tem.2010.10.003","volume":"22","author":"VT Samuel","year":"2011","unstructured":"Samuel VT (2011) Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol Metab 22(2):60\u201365. \nhttps:\/\/doi.org\/10.1016\/j.tem.2010.10.003","journal-title":"Trends Endocrinol Metab"},{"key":"1895_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2015.11.009","volume":"90","author":"PD Prince","year":"2016","unstructured":"Prince PD, Lanzi CR, Toblli JE, Elesgaray R, Oteiza PI, Fraga CG, Galleano M (2016) Dietary (\u2212)-epicatechin mitigates oxidative stress, NO metabolism alterations, and inflammation in renal cortex from fructose-fed rats. Free Radic Biol Med 90:35\u201346. \nhttps:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.11.009","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"1895_CR47","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1089\/jmf.2011.0212","volume":"15","author":"RC Khanal","year":"2012","unstructured":"Khanal RC, Howard LR, Wilkes SE, Rogers TJ, Prior RL (2012) Effect of dietary blueberry pomace on selected metabolic factors associated with high fructose feeding in growing Sprague\u2013Dawley rats. J Med Food 15(9):802\u2013810. \nhttps:\/\/doi.org\/10.1089\/jmf.2011.0212","journal-title":"J Med Food"},{"key":"1895_CR48","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.toxrep.2014.02.003","volume":"1","author":"MS Zarzecki","year":"2014","unstructured":"Zarzecki MS, Araujo SM, Bortolotto VC, de Paula MT, Jesse CR, Prigol M (2014) Hypolipidemic action of chrysin on Triton WR-1339-induced hyperlipidemia in female C57BL\/6 mice. Toxicol Rep 1:200\u2013208. \nhttps:\/\/doi.org\/10.1016\/j.toxrep.2014.02.003","journal-title":"Toxicol Rep"},{"key":"1895_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jnutbio.2016.10.007","volume":"40","author":"M Ichimura","year":"2017","unstructured":"Ichimura M, Masuzumi M, Kawase M, Sakaki M, Tamaru S, Nagata Y, Tanaka K, Suruga K, Tsuneyama K, Matsuda S, Omagari K (2017) A diet-induced Sprague\u2013Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis. J Nutr Biochem 40:62\u201369. \nhttps:\/\/doi.org\/10.1016\/j.jnutbio.2016.10.007","journal-title":"J Nutr Biochem"},{"issue":"6","key":"1895_CR50","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s00394-017-1492-1","volume":"57","author":"S Jeyapal","year":"2018","unstructured":"Jeyapal S, Putcha UK, Mullapudi VS, Ghosh S, Sakamuri A, Kona SR, Vadakattu SS, Madakasira C, Ibrahim A (2018) Chronic consumption of fructose in combination with trans fatty acids but not with saturated fatty acids induces nonalcoholic steatohepatitis with fibrosis in rats. Eur J Nutr 57(6):2171\u20132187. \nhttps:\/\/doi.org\/10.1007\/s00394-017-1492-1","journal-title":"Eur J Nutr"},{"issue":"5","key":"1895_CR51","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","volume":"61","author":"S Softic","year":"2016","unstructured":"Softic S, Cohen DE, Kahn CR (2016) Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease. Dig Dis Sci 61(5):1282\u20131293. \nhttps:\/\/doi.org\/10.1007\/s10620-016-4054-0","journal-title":"Dig Dis Sci"},{"issue":"3","key":"1895_CR52","doi-asserted-by":"publisher","first-page":"155932581878983","DOI":"10.1177\/1559325818789835","volume":"16","author":"C Balta","year":"2018","unstructured":"Balta C, Ciceu A, Herman H, Rosu M, Boldura OM, Hermenean A (2018) Dose-dependent antifibrotic effect of chrysin on regression of liver fibrosis: the role in extracellular matrix remodeling. Dose Response 16(3):1559325818789835. \nhttps:\/\/doi.org\/10.1177\/1559325818789835","journal-title":"Dose Response"},{"issue":"5","key":"1895_CR53","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3892\/etm.2017.4181","volume":"13","author":"A Hermenean","year":"2017","unstructured":"Hermenean A, Mariasiu T, Navarro-Gonzalez I, Vegara-Meseguer J, Miutescu E, Chakraborty S, Perez-Sanchez H (2017) Hepatoprotective activity of chrysin is mediated through TNF-alpha in chemically-induced acute liver damage: an in vivo study and molecular modeling. Exp Ther Med 13(5):1671\u20131680. \nhttps:\/\/doi.org\/10.3892\/etm.2017.4181","journal-title":"Exp Ther Med"},{"issue":"5","key":"1895_CR54","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1097\/HJH.0000000000000551","volume":"33","author":"AV Klein","year":"2015","unstructured":"Klein AV, Kiat H (2015) The mechanisms underlying fructose-induced hypertension: a review. J Hypertens 33(5):912\u2013920. \nhttps:\/\/doi.org\/10.1097\/HJH.0000000000000551","journal-title":"J Hypertens"},{"issue":"1","key":"1895_CR55","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/2231-0738.124615","volume":"4","author":"V Ramanathan","year":"2014","unstructured":"Ramanathan V, Thekkumalai M (2014) Role of chrysin on hepatic and renal activities of N\u03c9-nitro-l-arginine-methylester induced hypertensive rats. Int J Nutr Pharmacol Neurol Dis 4(1):58\u201363. \nhttps:\/\/doi.org\/10.4103\/2231-0738.124615","journal-title":"Int J Nutr Pharmacol Neurol Dis"},{"key":"1895_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-018-0761-y","author":"R Veerappan","year":"2018","unstructured":"Veerappan R, Malarvili T (2018) Chrysin pretreatment improves angiotensin system, cGMP concentration in L-NAME induced hypertensive rats. Indian J Clin Biochem. \nhttps:\/\/doi.org\/10.1007\/s12291-018-0761-y","journal-title":"Indian J Clin Biochem"},{"issue":"7","key":"1895_CR57","doi-asserted-by":"publisher","first-page":"e13162","DOI":"10.14814\/phy2.13162","volume":"5","author":"KL Gordish","year":"2017","unstructured":"Gordish KL, Kassem KM, Ortiz PA, Beierwaltes WH (2017) Moderate (20%) fructose-enriched diet stimulates salt-sensitive hypertension with increased salt retention and decreased renal nitric oxide. Physiol Rep 5(7):pii: e13162. \nhttps:\/\/doi.org\/10.14814\/phy2.13162","journal-title":"Physiol Rep"},{"issue":"2","key":"1895_CR58","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1161\/01.HYP.0000111136.86976.26","volume":"43","author":"K Shinozaki","year":"2004","unstructured":"Shinozaki K, Ayajiki K, Nishio Y, Sugaya T, Kashiwagi A, Okamura T (2004) Evidence for a causal role of the renin\u2013angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 43(2):255\u2013262. \nhttps:\/\/doi.org\/10.1161\/01.HYP.0000111136.86976.26","journal-title":"Hypertension"},{"issue":"4","key":"1895_CR59","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/HCO.0b013e3281532b53","volume":"22","author":"H Hitomi","year":"2007","unstructured":"Hitomi H, Kiyomoto H, Nishiyama A (2007) Angiotensin II and oxidative stress. Curr Opin Cardiol 22(4):311\u2013315. \nhttps:\/\/doi.org\/10.1097\/HCO.0b013e3281532b53","journal-title":"Curr Opin Cardiol"},{"issue":"8","key":"1895_CR60","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1161\/01.RES.0000163631.07205.fb","volume":"96","author":"H Cai","year":"2005","unstructured":"Cai H (2005) NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res 96(8):818\u2013822. \nhttps:\/\/doi.org\/10.1161\/01.RES.0000163631.07205.fb","journal-title":"Circ Res"},{"key":"1895_CR61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.regpep.2013.06.001","volume":"185","author":"MA Mayer","year":"2013","unstructured":"Mayer MA, H\u00f6cht C, Giani JF, Mu\u00f1oz MC, Carranza A, Taira CA, Dominici FP, Puy\u00f3 AM, Fern\u00e1ndez BE (2013) Central insulin\u2013angiotensin II interaction in blood pressure regulation in fructose overloaded rats. Regul Pept 185:37\u201343. \nhttps:\/\/doi.org\/10.1016\/j.regpep.2013.06.001","journal-title":"Regul Pept"},{"issue":"2","key":"1895_CR62","doi-asserted-by":"publisher","first-page":"147032031664291","DOI":"10.1177\/1470320316642915","volume":"17","author":"MM Bundalo","year":"2016","unstructured":"Bundalo MM, Zivkovic MD, Romic SD, Tepavcevic SN, Koricanac GB, Djuric TM, Stankovic AD (2016) Fructose-rich diet induces gender-specific changes in expression of the renin\u2013angiotensin system in rat heart and upregulates the ACE\/AT1R axis in the male rat aorta. J Renin Angiotensin Aldosterone Syst 17(2):1470320316642915. \nhttps:\/\/doi.org\/10.1177\/1470320316642915","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"1895_CR63","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1475-2840-10-114","volume":"10","author":"X Xu","year":"2011","unstructured":"Xu X, Tu L, Wang L, Fang X, Wang DW (2011) CYP2J3 gene delivery reduces insulin resistance via upregulation of eNOS in fructose-treated rats. Cardiovasc Diabetol 10:114. \nhttps:\/\/doi.org\/10.1186\/1475-2840-10-114","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"1895_CR64","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1055\/s-2002-34400","volume":"68","author":"IC Villar","year":"2002","unstructured":"Villar IC, Jimenez R, Galisteo M, Garcia-Saura MF, Zarzuelo A, Duarte J (2002) Effects of chronic chrysin treatment in spontaneously hypertensive rats. Planta Med 68(9):847\u2013850. \nhttps:\/\/doi.org\/10.1055\/s-2002-34400","journal-title":"Planta Med"},{"issue":"1","key":"1895_CR65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000328435","volume":"94","author":"RJ Denver","year":"2011","unstructured":"Denver RJ, Bonett RM, Boorse GC (2011) Evolution of leptin structure and function. Neuroendocrinology 94(1):21\u201338. \nhttps:\/\/doi.org\/10.1159\/000328435","journal-title":"Neuroendocrinology"},{"issue":"1","key":"1895_CR66","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuropharm.2011.12.010","volume":"63","author":"HJ Harwood Jr","year":"2012","unstructured":"Harwood HJ Jr (2012) The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. Neuropharmacology 63(1):57\u201375. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2011.12.010","journal-title":"Neuropharmacology"},{"issue":"11","key":"1895_CR67","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/hr.2011.97","volume":"34","author":"Y Zamami","year":"2011","unstructured":"Zamami Y, Takatori S, Hobara N, Yabumae N, Tangsucharit P, Jin X, Hashikawa N, Kitamura Y, Sasaki K, Kawasaki H (2011) Hyperinsulinemia induces hypertension associated with neurogenic vascular dysfunction resulting from abnormal perivascular innervations in rat mesenteric resistance arteries. Hypertens Res 34(11):1190\u20131196. \nhttps:\/\/doi.org\/10.1038\/hr.2011.97","journal-title":"Hypertens Res"},{"issue":"2","key":"1895_CR68","doi-asserted-by":"publisher","first-page":"155932581771178","DOI":"10.1177\/1559325817711782","volume":"15","author":"S Samarghandian","year":"2017","unstructured":"Samarghandian S, Farkhondeh T, Azimi-Nezhad M (2017) Protective effects of chrysin against drugs and toxic agents. Dose Response 15(2):1559325817711782. \nhttps:\/\/doi.org\/10.1177\/1559325817711782","journal-title":"Dose Response"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-019-01895-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00394-019-01895-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-019-01895-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T12:55:37Z","timestamp":1580820937000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00394-019-01895-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1895"],"URL":"https:\/\/doi.org\/10.1007\/s00394-019-01895-9","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"29 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}